Background Developing guidelines for the diagnosis and treatment of common cancers in
China based on the evidence-based practice, the availability of diagnosis and treatment …

Simple Summary Radiotherapy (RT) is a cornerstone in the adjuvant treatment of breast
cancer. Continuous technical improvements allow better sparing of organs at risk compared …

Background For the past 20 years, twice-daily thoracic radiotherapy with concurrent
chemotherapy has been the treatment of choice for limited-stage small-cell lung cancer (LS …

Background and purposes Data on the carbon footprint of external beam radiotherapy
(EBRT) are scarce. Reliable and exhaustive data, including a detailed carbon inventory, are …

Introduction Changes to the tumour bed following oncoplastic breast surgery complicate the
administration of adjuvant radiotherapy. Consensus guidelines have called for improved …

Background Pathological complete response (pCR) is a well-established prognostic factor in
breast cancer treated with neoadjuvant systemic therapy (naST). The determining factors of …

The management of axillary lymph nodes in breast cancer is continually evolving. Recent
data now support omitting axillary lymph node dissection (ALND) in most patients with …

Background Whether radiotherapy can improve the long-term survival of HER-2+ metastatic
breast cancer remains unclear. We launched this study to explore the effect of HER-2+ …

Opinion Statement Recent advancements in the treatment of early-stage breast cancer have
significantly shifted the radiotherapy landscape. Traditionally, the standard of care included …

Background The effectiveness and safety of moderately hypofractionated radiotherapy
(HFRT) in patients undergoing breast-conserving surgery (BCS) has been demonstrated in …